342 related articles for article (PubMed ID: 12368745)
1. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.
Zhang L; Hagen PO; Kisslo J; Peppel K; Freedman NJ
J Vasc Surg; 2002 Oct; 36(4):824-32. PubMed ID: 12368745
[TBL] [Abstract][Full Text] [Related]
2. Perivascular treatment with azathioprine reduces neointimal hyperplasia in experimental vein grafts.
Schachner T; Heiss S; Zipponi D; Tzankov A; Bernecker O; Kroell A; Laufer G; Bonatti J
Heart Surg Forum; 2006; 9(1):E515-7. PubMed ID: 16401538
[TBL] [Abstract][Full Text] [Related]
3. Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetes.
Salzberg SP; Filsoufi F; Anyanwu A; von Harbou K; Karlof E; Carpentier A; Dansky HM; Adams DH
Circulation; 2006 Jul; 114(1 Suppl):I302-7. PubMed ID: 16820590
[TBL] [Abstract][Full Text] [Related]
4. Mouse model of venous bypass graft arteriosclerosis.
Zou Y; Dietrich H; Hu Y; Metzler B; Wick G; Xu Q
Am J Pathol; 1998 Oct; 153(4):1301-10. PubMed ID: 9777962
[TBL] [Abstract][Full Text] [Related]
5. Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts.
Schachner T; Zou Y; Oberhuber A; Mairinger T; Tzankov A; Laufer G; Ott H; Bonatti J
Eur J Cardiothorac Surg; 2004 Apr; 25(4):585-90. PubMed ID: 15037276
[TBL] [Abstract][Full Text] [Related]
6. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells.
Zhang L; Peppel K; Brian L; Chien L; Freedman NJ
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2277-83. PubMed ID: 15486311
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
[TBL] [Abstract][Full Text] [Related]
8. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
Gessaroli M; Bombardi C; Giunti M; Bacci ML
J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
[TBL] [Abstract][Full Text] [Related]
9. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia.
Baek I; Bai CZ; Hwang J; Nam HY; Park JS; Kim DJ
J Vasc Surg; 2012 Mar; 55(3):806-814.e1. PubMed ID: 22226184
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor receptor-2 signaling attenuates vein graft neointima formation by promoting endothelial recovery.
Zhang L; Sivashanmugam P; Wu JH; Brian L; Exum ST; Freedman NJ; Peppel K
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):284-9. PubMed ID: 18006858
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue changes in a mouse model of vein graft disease.
Schachner T; Heiss S; Mayr T; Steger C; Zipponi D; Reisinger P; Bonaros N; Laufer G; Bonatti J
J Cardiovasc Surg (Torino); 2008 Apr; 49(2):269-76. PubMed ID: 18431349
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
Torsney E; Mayr U; Zou Y; Thompson WD; Hu Y; Xu Q
Circ Res; 2004 Jun; 94(11):1466-73. PubMed ID: 15117816
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis.
Sawada Y; Onoda K; Imanaka-Yoshida K; Maruyama J; Yamamoto K; Yoshida T; Shimpo H
Cardiovasc Res; 2007 Jun; 74(3):366-76. PubMed ID: 17383619
[TBL] [Abstract][Full Text] [Related]
15. Graft-extrinsic cells predominate in vein graft arterialization.
Zhang L; Freedman NJ; Brian L; Peppel K
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):470-6. PubMed ID: 14726410
[TBL] [Abstract][Full Text] [Related]
16. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
Vijayan V; Shukla N; Johnson JL; Gadsdon P; Angelini GD; Smith FC; Baird R; Jeremy JY
J Vasc Surg; 2004 Nov; 40(5):1011-9. PubMed ID: 15557918
[TBL] [Abstract][Full Text] [Related]
17. Induction of angiotensin converting enzyme in neointima after intravascular stent placement.
Nishibe T; Miyazaki K; Kudo F; Flores J; Miyazaki K; Nagato M; Kumada T; Yasuda K
Int Angiol; 2002 Sep; 21(3):250-5. PubMed ID: 12384646
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis.
Lee BH; Nam HY; Kwon T; Kim SJ; Kwon GY; Jeon HJ; Lim HJ; Lee WK; Park JS; Ko JY; Kim DJ
Nephrol Dial Transplant; 2006 Sep; 21(9):2432-8. PubMed ID: 16554328
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh.
Kohler TR; Toleikis PM; Gravett DM; Avelar RL
J Vasc Surg; 2007 May; 45(5):1029-1037; discussion 1037-8. PubMed ID: 17466798
[TBL] [Abstract][Full Text] [Related]
20. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
